Behandlungszufriedenheit bei Patienten mit zervikaler Dystonie: Subgruppenanalyse von INTEREST-IN-CD-2

BACKGROUND: Even though treatment guidelines recommend botulinum neurotoxin A (BoNT-A) as first line treatment for primary cervical dystonia (CD), there are only limited data on how BoNT-A-injections are administered in routine clinical practice. OBJECTIVE: This subgroup analysis evaluated patient s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Chi Wang, Schramm, Axel, Maisonobe, Pascal, Zaragatski, Emma, Sycha, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648643/
https://www.ncbi.nlm.nih.gov/pubmed/33942135
http://dx.doi.org/10.1007/s00115-021-01120-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648643/
https://www.ncbi.nlm.nih.gov/pubmed/33942135
http://dx.doi.org/10.1007/s00115-021-01120-1

Ejemplares similares